1. Home
  2. ALLR vs STSS Comparison

ALLR vs STSS Comparison

Compare ALLR & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • STSS
  • Stock Information
  • Founded
  • ALLR 2004
  • STSS 2017
  • Country
  • ALLR United States
  • STSS United States
  • Employees
  • ALLR N/A
  • STSS N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • STSS Medical/Dental Instruments
  • Sector
  • ALLR Health Care
  • STSS Health Care
  • Exchange
  • ALLR Nasdaq
  • STSS Nasdaq
  • Market Cap
  • ALLR 13.3M
  • STSS 5.5M
  • IPO Year
  • ALLR N/A
  • STSS 2022
  • Fundamental
  • Price
  • ALLR $0.98
  • STSS $5.65
  • Analyst Decision
  • ALLR
  • STSS
  • Analyst Count
  • ALLR 0
  • STSS 0
  • Target Price
  • ALLR N/A
  • STSS N/A
  • AVG Volume (30 Days)
  • ALLR 448.4K
  • STSS 2.7M
  • Earning Date
  • ALLR 08-04-2025
  • STSS 08-13-2025
  • Dividend Yield
  • ALLR N/A
  • STSS N/A
  • EPS Growth
  • ALLR N/A
  • STSS N/A
  • EPS
  • ALLR N/A
  • STSS N/A
  • Revenue
  • ALLR N/A
  • STSS N/A
  • Revenue This Year
  • ALLR N/A
  • STSS N/A
  • Revenue Next Year
  • ALLR N/A
  • STSS N/A
  • P/E Ratio
  • ALLR N/A
  • STSS N/A
  • Revenue Growth
  • ALLR N/A
  • STSS N/A
  • 52 Week Low
  • ALLR $0.61
  • STSS $3.36
  • 52 Week High
  • ALLR $10.59
  • STSS $2,224.20
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 51.07
  • STSS 43.42
  • Support Level
  • ALLR $0.80
  • STSS $5.15
  • Resistance Level
  • ALLR $0.98
  • STSS $5.82
  • Average True Range (ATR)
  • ALLR 0.06
  • STSS 0.61
  • MACD
  • ALLR 0.01
  • STSS 0.48
  • Stochastic Oscillator
  • ALLR 69.64
  • STSS 28.16

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.

Share on Social Networks: